文献速递中毒与环境急症消化、代谢与肾脏急症

甲基苯丙胺与阿片类药物使用与农村社区非致命性过量的关联

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities.
PubMed 文献 · JAMA Netw Open · 2022-08-01
一句话结论美国农村药物使用者中,甲基苯丙胺与阿片类共用的非致命性过量风险高于单用阿片类或单用甲基苯丙胺,作者认为减害与治疗干预须同时针对两类药物。

该研究基于2018年1月至2020年3月美国10个州农村社区药物使用者(PWUD)的横断面调查(改良链式转介抽样),纳入3048名过去30天注射吸毒或非注射阿片类以追求快感的农村PWUD。结果显示,63%(1878/2970)报告甲基苯丙胺与阿片类共用,甲基苯丙胺使用未加权患病率80%(95%CI 64%-90%)、加权79%(95%CI 57%-91%)。共用者非致命性过量比例22%(395/2854),高于单用阿片类14%(99例)和单用甲基苯丙胺6%(23例);共用较单用阿片类调整OR 1.45(95%CI 1.08-1.94;P=.01),较单用甲基苯丙胺调整OR 3.26(95%CI 2.06-5.14;P<.001)。作者认为减害和物质使用障碍治疗干预必须同时针对甲基苯丙胺和阿片类。

要点

  • 农村PWUD中63%(1878/2970)共用甲基苯丙胺与阿片类,单用阿片类24%(702例),单用甲基苯丙胺13%(390例)。
  • 共用者非致命性过量22%(395/2854),高于单用阿片类14%(99例)和单用甲基苯丙胺6%(23例)。
  • 共用较单用阿片类非致命性过量调整OR 1.45(95%CI 1.08-1.94;P=.01),较单用甲基苯丙胺调整OR 3.26(95%CI 2.06-5.14;P<.001)。
  • 共用者终生过量次数均值2.4(SD 4.2),高于单用阿片类1.7(SD 3.5;调整率比1.20;95%CI 1.01-1.43;P=.04)和单用甲基苯丙胺1.1(SD 2.9;调整率比1.81;95%CI 1.45-2.27;P<.001)。
  • 共用者报告尝试但未能获得物质使用治疗的比例最高(827例,44%),单用甲基苯丙胺30%(117例),单用阿片类36%(252例)(χ²₂=33.8;P<.001);单用甲基苯丙胺者仅17%(66例)有纳洛酮。

适用人群与场景

  • 美国10个州(伊利诺伊、肯塔基、新罕布什尔、马萨诸塞、北卡罗来纳、俄亥俄、俄勒冈、佛蒙特、西弗吉尼亚、威斯康星)农村社区中,报告过去30天注射吸毒或非注射阿片类以追求快感的药物使用者(PWUD)。

研究设计与关键结果

  • 研究类型:国家农村阿片类倡议(National Rural Opioid Initiative)于2018年1月至2020年3月开展的横断面调查,采用改良链式转介抽样;数据分析于2021年5月至2022年1月进行。
  • 样本量3048名参与者:1737名(57%)男性,2576名(85%)白人,225名(7.4%)美国印第安人;平均(SD)年龄36(10)岁。
  • 在2970名有任何阿片类或甲基苯丙胺使用的参与者中,1878名(63%)报告甲基苯丙胺与阿片类共用,702名(24%)单用阿片类,390名(13%)单用甲基苯丙胺。
  • 甲基苯丙胺使用未加权患病率80%(95%CI 64%-90%),加权患病率79%(95%CI 57%-91%)。
  • 非致命性过量在共用者中最高(395/2854名有非缺失过量数据的参与者[22%]),单用阿片类99例(14%),单用甲基苯丙胺23例(6%)。
  • 共用较单用阿片类:非致命性过量调整OR 1.45(95%CI 1.08-1.94;P=.01);共用较单用甲基苯丙胺:调整OR 3.26(95%CI 2.06-5.14;P<.001)。
  • 终生过量次数:共用者均值(SD)2.4(4.2)(中位数[IQR] 1[0-3]),单用阿片类1.7(3.5)(中位数[IQR] 0[0-2])(调整率比1.20;95%CI 1.01-1.43;P=.04),单用甲基苯丙胺1.1(2.9)(中位数[IQR] 0[0-1])(调整率比1.81;95%CI 1.45-2.27;P<.001)。
  • 尝试但未能获得物质使用治疗:共用者827例(44%),单用甲基苯丙胺117例(30%),单用阿片类252例(36%)(χ²₂=33.8;P<.001);单用甲基苯丙胺者仅66例(17%)有纳洛酮。

证据类型、等级与局限

  • 证据类型:横断面调查(National Rural Opioid Initiative),采用改良链式转介抽样。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,减害和物质使用障碍治疗干预必须同时针对甲基苯丙胺和阿片类,以降低农村社区中的过量。
  • 原文未据此给出其他推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Overdoses continue to increase in the US, but the contribution of methamphetamine use is understudied in rural communities.

OBJECTIVE: To estimate the prevalence of methamphetamine use and its correlates among people who use drugs (PWUD) in rural US communities and to determine whether methamphetamine use is associated with increased nonfatal overdoses.

DESIGN, SETTING, AND PARTICIPANTS: From January 2018 through March 2020, the National Rural Opioid Initiative conducted cross-sectional surveys of PWUD in rural communities in 10 states (Illinois, Kentucky, New Hampshire, Massachusetts, North Carolina, Ohio, Oregon, Vermont, West Virginia, and Wisconsin). Participants included rural PWUD who reported any past-30-day injection drug use or noninjection opioid use to get high. A modified chain-referral sampling strategy identified seeds who referred others using drugs. Data analysis was performed from May 2021 to January 2022.

EXPOSURES: Use of methamphetamine alone, opioids alone, or both.

MAIN OUTCOMES AND MEASURES: Unweighted and weighted prevalence of methamphetamine use, any past-180-day nonfatal overdose, and number of lifetime nonfatal overdoses.

RESULTS: Among the 3048 participants, 1737 (57%) were male, 2576 (85%) were White, and 225 (7.4%) were American Indian; the mean (SD) age was 36 (10) years. Most participants (1878 of 2970 participants with any opioid or methamphetamine use [63%]) reported co-use of methamphetamine and opioids, followed by opioids alone (702 participants [24%]), and methamphetamine alone (390 participants [13%]). The estimated unweighted prevalence of methamphetamine use was 80% (95% CI, 64%-90%), and the estimated weighted prevalence was 79% (95% CI, 57%-91%). Nonfatal overdose was greatest in people using both methamphetamine and opioids (395 of 2854 participants with nonmissing overdose data [22%]) vs opioids alone (99 participants [14%]) or methamphetamine alone (23 participants [6%]). Co-use of methamphetamine and opioids was associated with greater nonfatal overdose compared with opioid use alone (adjusted odds ratio, 1.45; 95% CI, 1.08-1.94; P = .01) and methamphetamine use alone (adjusted odds ratio, 3.26; 95% CI, 2.06-5.14; P < .001). Those with co-use had a mean (SD) of 2.4 (4.2) (median [IQR], 1 [0-3]) lifetime overdoses compared with 1.7 (3.5) (median [IQR], 0 [0-2]) among those using opioids alone (adjusted rate ratio, 1.20; 95% CI, 1.01-1.43; P = .04), and 1.1 (2.9) (median [IQR], 0 [0-1]) among those using methamphetamine alone (adjusted rate ratio, 1.81; 95% CI, 1.45-2.27; P < .001). Participants with co-use most often reported having tried and failed to access substance use treatment: 827 participants (44%) for both, 117 participants (30%) for methamphetamine alone, and 252 participants (36%) for opioids alone (χ22 = 33.8; P < .001). Only 66 participants (17%) using methamphetamine alone had naloxone.

CONCLUSIONS AND RELEVANCE: These findings suggest that harm reduction and substance use disorder treatment interventions must address both methamphetamine and opioids to decrease overdose in rural communities.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Korthuis PT, Cook RR, Foot CA, et al. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022. PMID: 35969400. doi:10.1001/jamanetworkopen.2022.26544

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。